AIIMS: No clear evidence that plasma therapy lowers mortality risk
Published
Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS here to assess the efficacy of this mode of treatment. The therapy involves taking antibodies from the blood of a person who has recovered from...
Full Article